Delhi High Court granted US drugmaker Pfizer an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans. India's health ministry banned the combination of chlorpheniramine maleate and codeine syrup, which Pfizer sells as the cough syrup Corex, in a notice over the weekend. Pfizer's Indian subsidiary appealed the ban through a writ petition in the New Delhi High Court, which granted the company a stay on Monday, pending the next court hearing, Pfizer said in a statement.Read more ...
Delhi High Court grants Pfizer temporary relief on cough syrup ban
The court said the government had not issued Pfizer a 'show cause notice' before banning the medicine
Reuters Last Updated at March 15, 2016 08:38 IST